Patent · US Active

Compounds for the treatment of hepatitis C

US8133884B2 · kind B2 · utility

2Cited by
16References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 4, 2009
Grant dateMar 13, 2012
Priority date
Expiry dateApr 1, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D498/08
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.